Intervir Therapeutics
2013
FOUNDED
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
1
INVESTORS
Description
Developer of drugs intended to treat viral diseases. The company's drugs are discovered to treat viral diseases using structure action relationships (SAR) that inhibit virus-host interactions required for egress and spread of infectious virus from the cell, enabling doctors to treat diseases caused by filoviruses (Ebola and Marburg), arenaviruses (Lassa Fever and JunÃn), influenza A virus and rhabdoviruses (rabies).
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 3160 Chestnut Street
- Suite 200
- Philadelphia, PA 19104
- United States
+1 (610) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Intervir Therapeutics’s full profile, request a free trial.
Intervir Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Aug-2015 | Completed | Startup |
Intervir Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| UPstart | Accelerator/Incubator | 000 0000 | 000000 0 |
Intervir Therapeutics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Mike Saporito | Chief Executive Officer & President |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »